Hong Kong Drug Office Updates Frequently Asked Questions’ Page
Hong Kong Drug Office has provided the latest set of frequently asked questions (FAQs) on their official website at the …
Hong Kong Drug Office Publishes Guideline on Pharmaceutical Products Recall
Hong Kong Drug Office has published some guidelines on the recall of pharmaceutical products in March 2022. Pharmaceutical products are …
Hong Kong Drug Office Publishes Guidance Notes on Registration of Pharmaceutical Products
Hong Kong Drug Office has published some guidance notes on the requirements of pharmaceutical products in February 2022. Registration of …
Hong Kong Drug Office Publishes Information on Requirement of Elemental Impurities Levels or Limits
Hong Kong Drug Office has published a guideline on the requirement of elemental impurities levels or limits in registered pharmaceutical …
Hong Kong Drug Office Publishes Latest Guidance for Import and Export Licences
Hong Kong Drug Office has published an updated guidance document for the application of import and export licences for pharmaceutical …
Hong Kong Drug Office Updates Frequently Asked Questions’ Page
Hong Kong Drug Office has updated and included the latest set of frequently asked questions (FAQs) on their official website …
Hong Kong Drug Office Publishes Guidance Note on Registration of Pharmaceutical Products Containing a New Chemical or Biological Entity
Hong Kong Drug Office has published a guidance note on the registration of pharmaceutical products containing a new chemical or …
Hong Kong Drug Office Updates Guidance for Adverse Drug Reaction Reporting Requirements to Add Considerations for Advanced Therapy Products
Hong Kong Drug Office updated Guidance for Adverse Drug Reaction Reporting Requirements to include special considerations for advanced therapy products in section 6, to …
Pharmacy and Poisons Board of Hong Kong has issued 5 New Guidances for Advanced Therapy Products
In June 2021, The Pharmacy and Poisons Board of Hong Kong issued 5 new guidances for Advanced Therapy Products. These guidances will be effective in August …
More News
ASEAN
Australia
Biologics/Biosimilars
Canada
China
Clinical Trials
Cosmetics
eCTD
EU
Global
Health Supplements
Herbal/Traditional Medicines
Hong Kong
India
Indonesia
Japan
Malaysia
Medical Devices
New Zealand
Pharmaceutical Drugs
Philippines
Singapore
South Korea
Sri Lanka
Switzerland
Taiwan
Thailand
United Kingdom
United States
Vietnam